These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38775970)

  • 1. A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk.
    Garate D; Thang CJ; Golovko G; Wilkerson MG; Barbieri JS
    Arch Dermatol Res; 2024 May; 316(5):196. PubMed ID: 38775970
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.
    Barbieri JS; Choi JK; Mitra N; Margolis DJ
    J Drugs Dermatol; 2018 Jun; 17(6):632-638. PubMed ID: 29879250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of prescribing patterns of tetracycline class antibiotics and spironolactone between advanced practice providers and physicians in the treatment of acne vulgaris.
    Guzman AK; Barbieri JS
    J Am Acad Dermatol; 2021 Apr; 84(4):1119-1121. PubMed ID: 32561369
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic antibiotics in acne: a dermatologic viewpoint.
    Sulzberger MB
    JAMA; 1973 May; 224(8):1184. PubMed ID: 4267243
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
    Armstrong AW; Hekmatjah J; Kircik LH
    J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
    Turowski CB; James WD
    Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
    Thang CJ; Garate D; O'Leary S; Golovko G; Wilkerson MG; Barbieri JS
    Br J Dermatol; 2024 May; 190(6):921-923. PubMed ID: 38530996
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Antibiotics in acne.
    Pochi PE
    N Engl J Med; 1976 Jan; 294(1):43-4. PubMed ID: 127946
    [No Abstract]   [Full Text] [Related]  

  • 9. Topicycline--a topical tetracycline for acne.
    Med Lett Drugs Ther; 1978 Apr; 20(7):35-6. PubMed ID: 147383
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility to infections during long-term treatment with tetracyclines in acne vulgaris.
    Björnberg A; Roupe G
    Dermatologica; 1972; 145(5):334-7. PubMed ID: 4265960
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
    Grandhi R; Alikhan A
    Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the Trial Design for a Comparative Effectiveness Study of Spironolactone versus Oral Antibiotics for Women With Acne: A Delphi Consensus Panel.
    Barbieri JS; Margolis DJ
    J Drugs Dermatol; 2020 Dec; 19(12):1238-1239. PubMed ID: 33346508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical antibiotics for acne vulgaris. Current usage.
    Stoughton RB
    Arch Dermatol; 1979 Apr; 115(4):486-9. PubMed ID: 155425
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical inquiries. Does treatment of acne with Retin A and tetracycline cause adverse effects?
    Kelly BF; Burroughs M; Mertens M
    J Fam Pract; 2004 Apr; 53(4):316-8. PubMed ID: 15068778
    [No Abstract]   [Full Text] [Related]  

  • 15. Minocycline vs tetracycline.
    Shubin JA
    J Fam Pract; 1995 Dec; 41(6):538. PubMed ID: 7500059
    [No Abstract]   [Full Text] [Related]  

  • 16. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
    Poinas A; Lemoigne M; Le Naour S; Nguyen JM; Schirr-Bonnans S; Riche VP; Vrignaud F; Machet L; Claudel JP; Leccia MT; Hainaut E; Beneton N; Dert C; Boisrobert A; Flet L; Chiffoleau A; Corvec S; Khammari A; Dréno B
    Trials; 2020 Jun; 21(1):571. PubMed ID: 32586344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
    Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
    J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
    Plovanich M; Weng QY; Mostaghimi A
    JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.
    Margolis DJ; Hoffstad O; Bilker W
    Br J Dermatol; 2007 Sep; 157(3):540-6. PubMed ID: 17596147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in therapy: the treatment of acne with antibiotics.
    South Med J; 1973 Apr; 66(4):494-6. PubMed ID: 4267707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.